 |
 |
 |
|
Evaluation of MK-2048 and Vicriviroc, Formulated as Single or Combination (MK-2048A) Intravaginal Rings, for Development as a Vaginal Microbicide
|
|
|
Reported by Jules Levin
HIV Research for Prevention, Chicago, IL - Pipelines and Platforms for Prevention 19 October 2016








|
|
|
 |
 |
|
|